Our studies in primary patient and Fujioka cells reveal the set of high-confidence protein interactions made by FOXC1 in AML and highlight in particular its interactions with proteins with critical roles in AML biology: RUNX1 and CEBPA. This evidence concerns the gene CEBPA and acute myeloid leukemia.